^○Takahiro SHINKAI (Dept. of Psychiatry, University of Occupational & Environmental Health)

^○Reiji YOSHIMURA (Dep. of Psychiatry, Univ. Occup and Envir Health, Japan)

^○Kunihiro IWAMOTO (Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan)

^○Atsuko IKENOUCHI^{1, 2} (1. Department of Psychiatry, University of Occupational and Environmental Health, Japan, 2. Wakayama tsukushi medical welfare center)

^○Norio FURUKORI (Department of Psychiatry, Dokkyo Medical School, School of Medicine, Japan)

^○Ryota HASHIMOTO (Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan)

^○Ken INADA (Dept. of Psychiatry, Tokyo Women's Medical University, Tokyo, Japan)

^○Norio FURUKORI (Department of Psychiatry, Dokkyo Medical School, School of Medicine, Japan)

^○Hiroyoshi TAKEUCHI¹, Tetsufumi KANAZAWA², Koki ITO³, Kazuto OYA⁴ (1. Department of Neuropsychiatry, Keio University School of Medicine, 2. Department of Neuropsychiatry, Osaka Medical College, 3. Department of Psychiatry, Hokkaido University School of Medicine, 4. Department of Psychiatry, Fujita Health University School of Medicine)

^○Aran TAJIKA¹, Seiichiro TARUTANI², Hikaru HORI ³, Yuki MATSUDA⁴, Atsunobu MURATA⁵, Taishiro KISHIMOTO⁶ (1. Department of Psychiatry, Kyoto University Hospital, 2. Shin-Abuyama Hospital, Osaka Institute of Clinical Psychiatry, 3. Department of Psychiatry, School of Medicine, University of Occupational and Environemental Health, 4. Department of Psychiatry Jikei University School of Medicine, 5. Kyowa Hospital Pharmacy, 6. Department of Neuropsychiatry, Keio University School of Medicine)

^○Yoshiteru TAKEKITA¹, Shunichiro IKEDA¹, Shusuke NUMATA², Enami SAWAYAMA³, Hiroshi KIMURA^{4, 5}, Ikuo NOMURA^{6, 7}, Taro SUWA⁸ (1. Department of Neuropsychiatry, Kansai Medical University, 2. Department of Psychiatry,Graduate School of Biomedical Science, Tokushima University, 3. Department of Psychiatry, Kitasato University School of Medicine, 4. Department of psychiatry, Gakuji-Kai Kimura Hospital, 5. Department of psychiatry, Graduate School of Medicine, Chiba University, 6. Department of Psychiatry, Fujita Health University School of Medicine, 7. Department of Psychiatry, Moriyama Integrated Mental Care Hospital, 8. Department of Psychiatry, Graduate School of Medicine, Kyoto University )

^○Itaru MIURA (Department of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima, Japan)

^○Takashi TSUBOI¹, Masakazu HATANO², Tsutomu NAGAI³, Tsuyoshi SASAKI⁴, Haruhiko ODA⁵, Satoru ESUMI⁶, Hiroki YAMADA⁷, Hiroshi KADOTANI⁸, Yasuhiko HASHIMOTO⁹, Tetsu TOMITA¹⁰ (1. Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan, 2. Department of Clinical Pharmacy, Fujita Health University School of Medicine, Aichi, Japan, 3. Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan, 4. Department of Child Psychiatry, Chiba-University Hospital, Chiba, Japan, 5. Hyogo Mental Health Center, Hyogo, Japan, 6. Department of Pharmacy, Okayama University Hospital, Okayama, Japan, 7. Department of Psychiatry, School of Medicine, Showa University, Tokyo, Japan, 8. Department of Sleep and Behavioral Sciences, Shiga University of Medical Science, Shiga, Japan, 9. Factly of clinical pharmacy, KobeGakuin university, Hyogo, Japan, 10. Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Aomori, Japan)

^○Yoshikazu TAKAESU (Department of Neuropsychiatry, Kyorin University, School of Medicine)

^○Omi WATANABE¹, Kiyotaka NEMOTO², Takaaki YASUDA³, Saya KIKUCHI⁴, Masanobu ITO⁵, Toshihito SUZUKI⁶ (1. Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, 2. Department of Psychiatry, Faculty of Medicine, University of Tsukuba, 3. Department of Psychiatry, Saitama Medical Center, Saitama Medical University, 4. Department of Psychiatry, Tohoku University Hospital, 5. Department of Psychiatry, Juntendo University Faculty of Medicine, 6. Department of Psychiatry, Juntendo Koshigaya Hospital, Juntendo University School of Medicine)

^○Masaki KATO (Department of Neuropsychiatry, Kansai Medical University)

^○Harukazu SUZUKI¹, Takahiro SUZUKI^{1, 2}, Shuhei NOGUCHI¹, Shubham GOYAL¹, Shiori MAEDA¹, Erina FURUHATA¹, Yuri SHIMIZU¹, Mami KISHIMA¹, Hajime NISHIMURA¹, Takeya KASUKAWA¹ (1. Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan, 2. Yokohama City University)

^○Yasutaka ANRAKU^{1, 2} (1. Department of Enginnering, The University of Tokyo, Tokyo, Japan, 2. Innovation Center of NanoMedicine (iCONM), Kawasaki Institute of Industrial Promotion, Kawasaki, Japan)

^○Osamu TAKIKAWA (NCGG / AMED)

^○Takeshi TERAO (Department of Neuropschiatry, Oita University Faculty of Medicine)

^○Takeshi INOUE (Department of Psychiatry, Tokyo Medical University)

^○Minoru TAKESHIMA^{1, 2} (1. Meishinkai Shibata Hospital, 2. Department of Psychiatry, Tokyo Medical University)

^○Takeshi TERAO (Department of Neuropschiatry, Oita University Faculty of Medicine)

^○Hirofumi HIRAKAWA, Masanao SHIRAHAMA, Takeshi TERAO ( Department of Neuropsychiatry, Oita University Faculty of Medicine,Yufu-city, Oita, Japan)

^○Takeshi INOUE (Department of Psychiatry, Tokyo Medical University)

^○Hideo SHIGEMATSU (NHO Shizuoka Institute of Epilepsy and Neurological Disorders)

^○Akihiko KONDO (Department of Neurological Surgery, NHO Shizuoka Institute of Epilepsy and Neurological Disorders)

^○Masahiro MIZOBUCHI (Epilepsy Center, Department of Neurology, Nakamura Memorial Hospital, Sapporo, Japan)

^○Takuji NISHIDA (NHO Shizuoka Institute of Epilepsy and Neurological Disorders)

^○Ataru INAGAKI (College of Education, Psychology and Human Studies, Aoyama Gakuin University)

^○Shinichi NOTO (Faculty of Rehabilitation，Niigata University of Health and Welfare)

^○Taishiro KISHIMOTO (Department of Neuropsychiatry, Keio University School of Medicine)

^○Kensuke YOSHIMURA¹, Hiroshi NARUSE¹, Shinjiro KIKUCHI² (1. Center for Next Generation of Community Health, Chiba University Hospital, Chiba, Japan. , 2. Department of Cognitive Behavioral Physiology, Graduate School of Medicine, Chiba University, Chiba, Japan)

^○Yoshiaki UYAMA (Pharmaceuticals and Medical Devices Agency)

^○Masaomi IYO (Department of Psychiatry, Graduate School of Medicine, Chiba University)

^○Yuki MATSUI¹, Taro KISHI², Nakao IWATA² (1. Jindai Hospital, Aichi, Japan, 2. Fujita Health University, School of Medicine, Department of Psychiatry)

^○Yoshiteru TAKEKITA (Department of Neuropsychiatry, Kansai Medical University)

^○Taro SUWA (Department of Psychiatry, Graduate School of Medicine, Kyoto University)

^○Nobuhisa KANAHARA (Center for Forensic Mental Health, Chiba University, Japan)

^○Tomofumi MIURA (Department of Psychiatry, NHO Kokura Medical Center)

^○Toshinori NAKAMURA (Department of Psychiatry, Shinshu University School of Medicine, Matsumoto, Nagano, Japan)

^○Hikaru HORI (Department of psychiatry, school of medicine, University of Occupational and Environmental Health, Kitakyushu, Japan)

^○Takahiro A. KATO (Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University)

^○Takeshi TERAO (Department of Neuropschiatry, Oita University Faculty of Medicine)

^○Naohisa UCHIMURA¹, Toshihito SUZUKI² (1. Department of Neuropsychiatry,Kurume University School of Medicine, 2. Department of Psychiatry, Juntendo Koshigaya Hospital)

^○Hiroshi YAMASHITA, Kenichi YAMANE, Daisuke KATSUKI, Kanako TAKADA, Minako MATSUMOTO (Department of Child Psychiatry Kyushu University Hospital)

^○Kiyotaka NEMOTO (Department of Psychiatry, Faculty of Medicine University of Tsukuba, Ibaraki, Japan)

^○Masanobu ITO (Department of Psychiatry, Juntendo University Faculty of Medicine, Tokyo, Japan)

^○Kazuhiro TAKUMA^{1, 2, 3}, Yuta HARA^{3, 4, 5}, Yukio AGO^{3, 4, 6}, Hitoshi HASHIMOTO^{2, 4, 7, 8}, Takanobu NAKAZAWA^{1, 4}, Toshio MATSUDA³ (1. Department of Pharmacology, Graduate School of Dentistry, Osaka University, Suita, Japan, 2. United Graduate School of Child Development, Osaka University, Osaka, Japan, 3. Laboratory of Medicinal Pharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 4. Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 5. Cell Biology Laboratory, Faculty of Pharmacy, Kindai University, Osaka, Japan, 6. Laboratory of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 7. Division of Bioscience, Institute for Datability Science, Osaka University, Osaka, Japan, 8. Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, Japan)

^○Atsuo NAKAGAWA^{1, 2}, Toshiaki KIKUCHI², Norio FURUKORI³, Reiji YOSHIMURA⁴, Masaki KATO⁵, Takashi TSUBOI⁶, Yusuke KONNO⁴, Norio SUGAWARA³, Naoto ADACHI⁷, Yukihisa KUBOTA⁷, Takaharu AZEGAWA⁷, Hitoshi UEDA⁷, Koji EDAGAWA⁷, Eiichi KATSUMOTO⁷, Eiichiro GOTO⁷, Seiji HONGO⁷, Koichiro WATANABE⁶ (1. Keio University Hospital Clinical and Translational Research Center, Tokyo, Japan , 2. Keio University School of Medicine, Department of Neuropsychiatry, 3. Dokkyo Medical University School of Medicine, Department of Psychiatry, 4. University of Occupational and Environmental Health, Department of Psychiatry, 5. Kansai Medical School, Department of Neuropsychiatry, 6. Kyorin University School of Medicine, Department of Neuropsychiatry, 7. Japanese Association of Neuro-Psychiatric Clinics)

^○Masaki KATO (Department of Neuropsychiatry, Kansai Medical University)

^○Yusuke KONNO¹, Yoshihisa FUJINO², Reiji YOSHIMURA¹, Atsuo NAKAGAWA³, Toshiaki KIKUCHI³, Norio FURUKORI⁴, Masaki KATO⁵, Takashi TSUBOI⁶, Norio SUGAWARA⁴, Naoto ADACHI⁷, Yukihisa KUBOTA⁷, Takaharu AZEGAWA⁷, Hitoshi UEDA⁷, Koji EDAGAWA⁷, Eiichi KATSUMOTO⁷, Eiichiro GOTO⁷, Seiji HONGO⁷, Koichiro WATANABE⁶ (1. Department of Psychiatry, University of Occupational and Environmental Health, Fukuoka, Japan, 2. Department of Environmental Epidemiology Institute of Industrial Ecological Sciences University of Occupational and Environmental Health, Japan, 3. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 4. Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan, 5. Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan, 6. Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan, 7. Japanese Association of Neuro-Psychiatric Clinics)

^○Keita TOKUMITSU¹, Norio YASUI-FURUKORI¹, Reiji YOSHIMURA², Masaki KATO³, Atsuo NAKAGAWA⁴, Toshiaki KIKUCHI^{1, 4}, Takashi TSUBOI⁵, Naoto ADACHI⁶, Yukihisa KUBOTA⁶, Takaharu AZEKAWA⁶, Hitoshi UEDA⁶, Koji EDAGAWA⁶, Eiichi KATSUMOTO⁶, Eiichiro GOTO⁶, Seiji HONGO⁶, Koichiro WATANABE⁶ (1. Department of Psychiatry, Dokkyo Medical University, 2. Department of Psychiatry, University of Occupational and Environmental Health, 3. Department of Neuropsychiatry, Kansai Medical University, 4. Department of Neuropsychiatry, Keio University School of Medicine, 5. Department of Neuropsychiatry, Kyorin University School of Medicine, 6. Japanese Association of Neuro-Psychiatric Clinics)

^○Atsushi TAKATA (Yokohama City University)

^○Masashi IKEDA (Department of Psychiatry, Fujita Health University School of Medicine, Aichi, Japan)

^○Kazunari YOSHIDA^{1, 2} (1. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 2. Pharmacogenetics Research Clinic, Centre for Addiction and Mental Health, Toronto, ON, Canada)

^○Masaki KATO (Department of Neuropsychiatry, Kansai Medical University)

^○Kaoruhiko KUBO¹, Fumiaki KUMAGAI³, Masaru MIMURA², Hiroyuki UCHIDA² (1. Tsurugaoka Garden Hospital, 2. Department of Neuropsychiatry, Keio University School of Medicine, 3. Kawasaki Municipal Hospital)

^○Fumiaki KUMAGAI¹, Kaoruhiko KUBO², Masaru MIMURA³, Hiroyuki UCHIDA³ (1. Department of psychiatry, Kawasaki Municipal Hospital, Kanagawa, Japan, 2. Tsurugaoka Garden Hospital, Tokyo, Japan, 3. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)

^○Norio SUGAWARA, Norio YASUI-FURUKORI (Department of Psychiatry, Dokkyo Medical University School of Medicine)

^○Toshiaki A. FURUKAWA (Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine / School of Public Health)

^○Koichiro WATANABE (Department of Neuropsychiatry, Kyorin University School of Medicine)

^○Masaomi IYO^{1, 2} (1. Department of Psychiatry, Graduate School of Medicine, Chiba University, Japan, 2. Center for Forensic Psychiatry, Chiba University, Japan)

^○Yasunori ODA (Department of Psychiatry, Chiba University Graduate School of Medicine)

^○Hiroyoshi TAKEUCHI (Department of Neuropsychiatry, Keio University School of Medicine)

^○Hiroyuki UCHIDA (Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)

^○Hiroyuki UCHIDA (Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan)

^○菊池 結花 (秋田大学医学部神経運動器学講座精神科学分野)

^○Yumiko AKAMINE¹, Yuka KIKUCHI² (1. Department of Pharmacy, Akita University Hospital, 2. Department of Neuropsychiatry, Akita University Graduate School of Medicine)

^○NAOYA KIDA¹, MASARU MURAKAMI², TAKU OTSURU¹, SAIKO KUBO¹, TASTUO NAKAHARA³, KIJIRO HASHIMOTO³ (1. National Hospital Organization Ryukyu Hospital, 2. National Hospital Organization Saigata Medical Center, 3. National Hospital Organization Hizen Psychiatric Center)

^○Masaru MURAKAMI (NHO Saigata Medical Center)

^○TAKAHASHI MASAHIRO¹, Sachiyo MORITA², Masahiro MATSUO⁴, Michiya AKABANE³, Koji UENISHI³, Naoto YAMADA¹ (1. Social Welfare Corporation Kyoryokai Kamibayashi Anniversary Hospital, 2. Cancer center, Shiga-University of Medical Science , 3. Department of Pharmacy, Shiga-University of Medical Science, 4. Department of Psychiatry, Shiga-University of Medical Science)

^○Kohei KITAGAWA¹, Yuji YADA², Masafumi KODAMA^{1, 2}, Ryuhei SO², Daiki BABA³, Akiko KATAYAMA⁴, Takeko MAKIDA⁴, Yoshiki KISHI² (1. Department of Clinical Research, Okayama Psychiatric Medical Center, Okayama, Japan, 2. Department of Psychiatry, Okayama Psychiatric Medical Center, Okayama, Japan, 3. Department of Pharmacy, Okayama Psychiatric Medical Center, Okayama, Japan, 4. Department of Clinical Laboratory, Okayama Psychiatric Medical Center, Okayama, Japan)

^○Yoshiki KISHI (Okayama Psychiatric Medical Center)

^○Ken YONEZAWA^{1, 2}, Hiroki OZAWA¹ (1. Department of Neuropsychiatry, Unit of Translation Medicine Nagasaki University Graduate School of Biomedical Sciences, 2. Yuzuriha hospital pharmacy)

^○Hikaru HORI¹, Jun NAKAMURA², Reiji YOSHIMURA¹ (1. Department of psychiatry, school of medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, 2. Kitakyushu Koga Hospital)

^○サッサ タケシ (Shinkemigawa Mental Clinic)

^○馬場 元^1,2 (1. 順天堂大学大学院医学研究科精神・行動科学、2. 順天堂大学医学部附属順天堂越谷病院)

^○Naoto KAMIMURA (Department of Neuropsychiatry,Kochi Medical School ,Kochi University)

^○Junichi IGA (Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine)

^○Nio SHINTARO (Saiseikai Central Hospital)

^○Hajime BABA^{1, 2} (1. Department of Psychiatry & Behavioral Science, Juntendo Graduate School of Medicine, 2. Department of Psychiatry, Juntendo Koshigaya Hospital)

^○Shuichi UENO (Department of Neuropsychiatry, Ehime University)